Clinical Trials Directory

Trials / Conditions / AML/MDS

AML/MDS

7 registered clinical trials studyying AML/MDS — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingDanvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
NCT05986240
Montefiore Medical CenterPhase 1
Active Not RecruitingSENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Includi
NCT06325748
Senti BiosciencesPhase 1
RecruitingInnate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial
NCT05686538
Rigshospitalet, DenmarkPhase 2 / Phase 3
TerminatedStudy of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT
NCT04679194
Mana TherapeuticsPhase 1
RecruitingCD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
NCT04318678
St. Jude Children's Research HospitalPhase 1
CompletedDose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in P
NCT04139434
Newave Pharmaceutical IncPhase 1
Active Not RecruitingTolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients
NCT04097470
Stichting Hemato-Oncologie voor Volwassenen NederlandPhase 2